pharmacogenomics

Using Revel Health's health action platform, the partners will communicate and promote CLS's genetic testing offering to Medicare Advantage members.

The firm can now tell customers if their genotypes may impact their response to clopidogrel and citalopram without the need for confirmatory testing.

The software generates reports for pharmacogenomics, rare diseases, predispositions to common diseases, and nutrigenomics.

The initial investment is led by Debiopharm, which will collaborate with the Israeli startup to accelerate discovery of biomarkers for oncology drug response.

The MAC will consider PGx testing reasonable and necessary after a physician has narrowed a patient's treatment options to specific medications.

A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors.

Under the LCD, pharmacogenomic tests are covered when medications are being considered for use that are known to have a clinically actionable gene-drug interaction.